Vestibular cytotoxicity in gentamicin-treated frogs: a preliminary report

Tapan K Bhattacharyya1, Arvind Kumar

  • 1Department of Otoalaryngology-Head and Neck Surgery, University of Illinois at Chicago, 60612, USA. tbhatt@uic.edu

Abstract

Insights

Gentamicin (GM) treatment in frogs significantly reduced sensory hair cells (SNCs) in the vestibular organ. This study provides a baseline for understanding hair cell regeneration and assessing drug toxicity.

Area of Science:

  • Vestibular system research
  • Ototoxicity studies
  • Cell regeneration mechanisms

Background:

  • The vestibular system's sensory hair cells (SNCs) are crucial for balance.
  • Gentamicin (GM) is known to cause ototoxicity.
  • Understanding GM's effects is vital for drug development and regenerative medicine.

Purpose of the Study:

  • To quantify the immediate impact of intraperitoneal gentamicin (GM) on frog vestibular sensory hair cells (SNCs).
  • To establish a baseline for future studies on vestibular organ regeneration.
  • To assess the potential of gentamicin-induced damage as a model for studying cell regeneration.

Main Methods:

  • American bullfrogs received daily intraperitoneal doses of gentamicin (50-200 mg/kg) for 7 days.
  • Posterior semicircular duct cristae were processed for histological analysis.
  • Areal density of sensory cells (SNCs) and supporting cells (SPCs) was determined using microscopy and micrometry.

Main Results:

  • A 7-day gentamicin administration led to a significant decrease in the density of sensory hair cells (SNCs).
  • A corresponding increase in the density of supporting cells (SPCs) was observed.
  • Quantitative alterations in vestibular sensory and supporting cells were dose-dependent.

Conclusions:

  • Intraperitoneal gentamicin significantly reduces vestibular sensory hair cell density in frogs.
  • The observed increase in supporting cells may indicate a regenerative response.
  • This study provides a quantitative foundation for investigating vestibular hair cell regeneration and assessing drug-induced vestibulo-toxicity.